A hub of pharma innovation

The Japanese pharmaceutical market is the second largest in the world, accounting for around $100 billion of the total market share, according to the reports issued by the Japan Pharmaceutical Manufacturers Association. The local market has been dominated by brand drugs, with generics taking a lower share compared with other developed counties.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia

IndiaMart v CDSCO: A test of intermediary liability

31 March 2026 The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.

Asia

Part I: Ozempic goes generic as Novo’s key patent expires

20 March 2026 As the patent protecting semaglutide—the drug that made Novo Nordisk one of Europe's most valuable companies—expires in ten countries, the pressure mounts for prices and market leaders alike.

Asia

AstraZeneca partners with Chinese firm ahead of next obesity race

5 February 2026 The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market.

More features

Penile implant maker’s $17m trade secret award unravels

Appeals court eases Teva’s headache with reversal

Simmons & Simmons makes senior Asia trademark hire

Cancer drug researcher hit with suit over mutation-targeting tools

Novo Nordisk and OpenAI strike AI deal to boost drug discovery

Court narrows Mylan’s Copaxone suit but key claims survive

Patent office fee increases: What applicants must know

LSPN Awards USA: Meet the judges

A hub of pharma innovation

More on this story

Editor's picks

Editor's picks

More features